Kirk Randal J bought $136,327 worth of shares (96,686 units at $1.41) (SEC Form 4)

12/29/23 7:30:15 PM ET

$PGEN

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $PGEN alert in real time by email

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIRK RANDAL J

(Last)

(First)

(Middle)

C/O THIRD SECURITY, LLC

1881 GROVE AVENUE

(Street)

RADFORD

24141

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/28/2023

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	12/28/2023		P		96,686	A	$1.41⁽¹⁾	1,096,686	I	by Parkview 2020⁽²⁾
Common Stock								31,837,786	I	by R.J. Kirk DOT⁽²⁾
Common Stock								490,401	I	by JPK 2008⁽²⁾
Common Stock								3,703,398	I	by JPK 2009⁽²⁾
Common Stock								1,654,363	I	by JPK 2012⁽²⁾
Common Stock								489,438	I	by MGK 2008⁽²⁾
Common Stock								3,944,437	I	by MGK 2009⁽²⁾
Common Stock								1,637,040	I	by MGK 2011⁽²⁾
Common Stock								578,079	I	by ZSK 2008⁽²⁾
Common Stock								351,120	I	by ZSK 2009⁽²⁾
Common Stock								453,731	I	by Kellie L. Banks LTT⁽²⁾
Common Stock								1,015,604	I	by Sr. Staff 2015⁽²⁾
Common Stock								1,015,626	I	by Staff 2015⁽²⁾
Common Stock								13,520,789	I	by Kapital Joe⁽²⁾
Common Stock								1,144,481	I	by Spouse
Common Stock								1,403	I	by Lotus⁽²⁾
Common Stock								16,406,828	I	by Sunset 2020⁽²⁾
Common Stock								1,839,946	I	by Staff 2010⁽³⁾
Common Stock								1,383,858	I	by Staff 2009⁽³⁾
Common Stock								3,223,803	I	by Sr. Staff 2008⁽³⁾
Common Stock								691,929	I	by Incentive 2009⁽³⁾
Common Stock								1,384,408	I	by Incentive 2010⁽³⁾
Common Stock								311,287	I	by Staff 2001⁽³⁾
Common Stock								58,800	I	by Sr. Staff⁽³⁾
Common Stock								59,133	I	by Staff 2006⁽³⁾
Common Stock								118,266	I	by Sr. Staff 2006⁽³⁾
Common Stock								19,711	I	by Incentive 2006⁽³⁾
Common Stock								4,995,000	I	by Sr. Staff 2007⁽³⁾
Common Stock								2,497,500	I	by Staff 2007⁽³⁾
Common Stock								832,500	I	by Incentive 2007⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. On December 28, 2023, Parkview 2020 Limited Partnership ("Parkview 2020"), entered into a Stock Purchase Agreement with Jeffrey Kindler, a Director of the issuer, pursuant to which Parkview 2020 purchased from Mr. Kindler 96,686 shares of common stock of the issuer for an aggregate purchase price of $1.41, which purchase price was calculated based upon the closing price of the issuer's common stock on December 28, 2023.

2. Randal J. Kirk controls each of Parkview 2020, R.J. Kirk Declaration of Trust ("R.J. Kirk DOT"), JPK 2008 LLC ("JPK 2008"), JPK 2009 LLC ("JPK 2009"), JPK 2012 LLC ("JPK 2012"), MGK 2008 LLC ("MGK 2008"), MGK 2009 LLC ("MGK 2009"), MGK 2011 LLC ("MGK 2011"), ZSK 2008 LLC ("ZSK 2008"), ZSK 2009 LLC ("ZSK 2009"), Kellie L. Banks (2009) Long Term Trust ("Kellie L. Banks LTT"), Third Security Senior Staff 2015 LLC ("Sr. Staff 2015"), Third Security Staff 2015 LLC ("Staff 2015"), Kapital Joe, LLC ("Kapital Joe"), Lotus Capital (2000) Company, Inc. ("Lotus"), and Sunset 2020 LLC ("Sunset 2020"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

3. Randal J. Kirk controls each of Third Security Staff 2010 LLC ("Staff 2010"), Third Security Staff 2009 LLC ("Staff 2009"), Third Security Senior Staff 2008 LLC ("Sr. Staff 2008"), Third Security Incentive 2009 LLC ("Incentive 2009"), Third Security Incentive 2010 LLC ("Incentive 2010"), Third Security Staff 2001 LLC ("Staff 2001"), Third Security Senior Staff LLC ("Sr. Staff"), Third Security Staff 2006 LLC ("Staff 2006"), Third Security Senior Staff 2006 LLC ("Sr. Staff 2006"), Third Security Incentive 2006 LLC ("Incentive 2006"), Third Security Senior Staff 2007 LLC ("Sr. Staff 2007"), Third Security Staff 2007 LLC ("Staff 2007"), and Third Security Incentive 2006 LLC (incentive 2007"). Shares held by these entities may be deemed to be beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.

Remarks:

	/s/ Randal J. Kirk	12/29/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Get the next $PGEN alert in real time by email

Date	Price Target	Rating	Analyst
3/22/2024		Neutral → Underweight	JP Morgan
5/23/2023		Neutral	JP Morgan
11/18/2022	$7.00	Overweight	Cantor Fitzgerald

Kirk Randal J bought $136,327 worth of shares (96,686 units at $1.41) (SEC Form 4)

Chat with this insight

Recent Analyst Ratings for $PGEN

$PGEN Press Releases

Fastest customizable press release news feed in the world

Precigen Reports Third Quarter 2024 Financial Results and Business Updates

Precigen to Participate in the Stifel 2024 Healthcare Conference

Precigen to Participate in the 2024 Cantor Global Healthcare Conference

$PGEN Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

SVP, IP Affairs Perez Jeffrey Thomas bought $50,000 worth of shares (58,823 units at $0.85), increasing direct ownership by 9% to 743,097 units (SEC Form 4)

Director Kirk Randal J bought $19,999,999 worth of shares (23,529,411 units at $0.85) (SEC Form 4)